Skip to content

PVCT PROVECTUS BIOPHARMACEUTICA-A

Follow

COMMON STOCK (common), issuer CIK 315545

7 managers (7 13F filers) reported a position in PVCT shares at 2025-09-30, 229,412 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.

Managers
7
13F filers
7
New
0
Added
1
Reduced
0
Sold out
0
Shares held by filers
229,412

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
HOME FEDERAL BANK OF TENNESSEE100,000$8.9K<0.01%013F-HRTimeline
Wealth Preservation Advisors, LLC52,600$4.68K<0.01%+60013F-HRTimeline
Atlas Wealth LLC26,620$2.37K<0.01%013F-HRTimeline
ACADEMY CAPITAL MANAGEMENT20,000$1.78K<0.01%013F-HRTimeline
LBMC INVESTMENT ADVISORS, LLC20,000$1.78K<0.01%013F-HRTimeline
Financial Symmetry Inc10,191$907<0.01%013F-HRTimeline
HUNTINGTON NATIONAL BANKin group HUNTINGTON NATIONAL BANK1$00%013F-HRTimelineGroupValue filed as zero, left out of ratios.